NMRD (Nemaura Medical) Cyclically Adjusted FCF per Share: $-0.22 (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nemaura Medical Cyclically Adjusted FCF per Share?

Nemaura Medical NMRD Cyclically Adjusted FCF per Share is $-0.22 as of Dec. 2023.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Nemaura Medical's adjusted free cash flow per share for the three months ended in Dec. 2023 was $-0.052. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.22 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-17), Nemaura Medical's current stock price is $0.0001. Nemaura Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $-0.22. Nemaura Medical's Cyclically Adjusted Price-to-FCF of today is .


Nemaura Medical  (OTCPK:NMRD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Nemaura Medical Cyclically Adjusted FCF per Share Related Terms


Nemaura Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Nemaura Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nemaura Medical Cyclically Adjusted FCF per Share Chart

Nemaura Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.20

Nemaura Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.20 -0.21 -0.21 -0.22

NMRD vs THMO, MOTS, ABT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Nemaura Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nemaura Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nemaura Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Nemaura Medical's Cyclically Adjusted Price-to-FCF falls into.



Nemaura Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nemaura Medical's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.052/306.7460*306.7460
=-0.052

Current CPI (Dec. 2023) = 306.7460.

Nemaura Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.085 236.293 0.110
201406 -0.038 238.343 -0.049
201409 -0.015 238.031 -0.019
201412 -0.013 234.812 -0.017
201503 -0.011 236.119 -0.014
201506 -0.012 238.638 -0.015
201509 -0.014 237.945 -0.018
201512 -0.011 236.525 -0.014
201603 -0.027 238.132 -0.035
201606 -0.012 241.018 -0.015
201609 -0.015 241.428 -0.019
201612 -0.010 241.432 -0.013
201703 -0.025 243.801 -0.031
201706 -0.015 244.955 -0.019
201709 -0.034 246.819 -0.042
201712 -0.024 246.524 -0.030
201803 -0.132 249.554 -0.162
201806 -0.043 251.989 -0.052
201809 -0.054 252.439 -0.066
201812 -0.040 251.233 -0.049
201903 -0.061 254.202 -0.074
201906 -0.038 256.143 -0.046
201909 -0.060 256.759 -0.072
201912 -0.036 256.974 -0.043
202003 -0.042 258.115 -0.050
202006 -0.052 257.797 -0.062
202009 -0.087 260.280 -0.103
202012 -0.094 260.474 -0.111
202103 -0.071 264.877 -0.082
202106 -0.090 271.696 -0.102
202109 -0.089 274.310 -0.100
202112 -0.046 278.802 -0.051
202203 -0.094 287.504 -0.100
202206 -0.108 296.311 -0.112
202209 -0.097 296.808 -0.100
202212 -0.066 296.797 -0.068
202303 -0.091 301.836 -0.092
202306 -0.088 305.109 -0.088
202309 -0.112 307.789 -0.112
202312 -0.052 306.746 -0.052

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.22 mean?
Nemaura Medical (NMRD) has a Cyclically Adjusted FCF per Share of $-0.22 as of Dec. 2023. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nemaura Medical and its competitors.
Is Nemaura Medical's Cyclically Adjusted FCF per Share too high?
Nemaura Medical's current Cyclically Adjusted FCF per Share is $-0.22.
How does Nemaura Medical's Cyclically Adjusted FCF per Share compare to THMO and MOTS?
Nemaura Medical's Cyclically Adjusted FCF per Share of $-0.22 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nemaura Medical and its competitors. Nemaura Medical's current Cyclically Adjusted FCF per Share is $-0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nemaura Medical stock overvalued right now?
Nemaura Medical (NMRD) has a current Cyclically Adjusted FCF per Share of $-0.22. The current Cyclically Adjusted FCF per Share is $-0.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Nemaura Medical (NMRD), the current Cyclically Adjusted FCF per Share is $-0.22 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nemaura Medical Business Description

Address 57 West 57th Street, New York, NY, USA, 10019
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.